Sartorius Stedim Biotech S.A. (OTCMKTS:SDMHF – Get Free Report) saw a significant growth in short interest in May. As of May 15th, there was short interest totalling 35,300 shares, a growth of 23.4% from the April 30th total of 28,600 shares. Based on an average daily volume of 1,100 shares, the short-interest ratio is currently 32.1 days.
Sartorius Stedim Biotech Price Performance
OTCMKTS SDMHF remained flat at $216.65 during trading on Tuesday. Sartorius Stedim Biotech has a 1 year low of $158.00 and a 1 year high of $241.80. The firm’s fifty day simple moving average is $215.20 and its two-hundred day simple moving average is $207.11.
Wall Street Analysts Forecast Growth
Separately, Royal Bank of Canada downgraded Sartorius Stedim Biotech from an “outperform” rating to a “sector perform” rating in a report on Wednesday, May 21st.
About Sartorius Stedim Biotech
Sartorius Stedim Biotech SA engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products.
Further Reading
- Five stocks we like better than Sartorius Stedim Biotech
- Why Invest in High-Yield Dividend Stocks?
- Ollie’s Q1 Earnings: The Good, the Bad, and What’s Next
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Rocket Lab Expands Into Payloads: Should You Be Paying Attention?
- 3 Warren Buffett Stocks to Buy Now
- Qualcomm: A Technical Deep-Dive Confirms the Worst
Receive News & Ratings for Sartorius Stedim Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius Stedim Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
